drugset / Trial / NCT01282801

Venlafaxine Hydrochloride 150 mg Extended-Release Capsules Under Fed Conditions

NCT01282801

Phase 1 Completed 18 enrolled Teva Pharmaceuticals USA
RandomizedCrossoverOpen-label

Summary

The objective of this study was to compare the rate and extent of absorption of venlafaxine hydrochloride 150 mg extended-release capsules (test) versus Effexor® XR (reference) administered as 1 x 150 mg extended-release capsule under fed conditions.

Timeline

Start
2002-09
Primary completion
2002-10
Completion
2002-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Venlafaxine Small molecule 150 mg

Indications

No indication recorded.